JMP Securities downgraded Deciphera to Market Perform from Outperform after the company entered into an agreement to be acquired by Ono Pharmaceutical for $25.60 per share.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.